Abstract
Spinal cord stimulation (SCS) has become increasingly utilized for the treatment of various chronic pain conditions over the past two decades. However, despite these improvements, the same complications that were encountered in early SCS implantation surgery continue today, including postoperative surgical site infection (SSI). This literature review was conducted to review the surgical literature regarding the relationship between hemoglobin A1c (HbA1c), diagnosis of diabetes mellitus (DM), and risk of postoperative SSI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
